Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 105

Results For "RIL"

1244 News Found

Metropolis Healthcare opens MedEngage Scholarship programme
News | January 13, 2022

Metropolis Healthcare opens MedEngage Scholarship programme

The last date to apply for this program is 18th January 2022


AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons
Medical Device | January 13, 2022

AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales


Pfizer and Beam enter research collaboration for In Vivo base editing programme
Biotech | January 11, 2022

Pfizer and Beam enter research collaboration for In Vivo base editing programme

Four-year research collaboration combines Pfizer’s deep experience in global drug development, including programs utilizing messenger RNA (mRNA), lipid nanoparticles (LNP), and gene therapy, with Beam’s leadership in base editing and mRNA/LNP delivery technologies


Alembic receives tentative U.S.FDA approval for dronedarone tablets
Drug Approval | January 10, 2022

Alembic receives tentative U.S.FDA approval for dronedarone tablets

Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA


Moderna and Carisma Therapeutics partner to develop CAR-M therapeutics
Biotech | January 10, 2022

Moderna and Carisma Therapeutics partner to develop CAR-M therapeutics

Carisma to receive US $ 45 million up-front cash payment and investment by Moderna in the form of a US $ 35 million convertible note


AstraZeneca and Neurimmune to develop and commercialise NI006
Biotech | January 07, 2022

AstraZeneca and Neurimmune to develop and commercialise NI006

Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition


Domestic and emerging markets will drive pharma growth: ICRA
News | January 04, 2022

Domestic and emerging markets will drive pharma growth: ICRA

Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters


Comar expands packaging solutions with Omega acquisition
Packaging | December 30, 2021

Comar expands packaging solutions with Omega acquisition

The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise


RaphaCure partners with Zeebon for foraying into North East market
Clinical Trials | December 28, 2021

RaphaCure partners with Zeebon for foraying into North East market

Zeebon is the largest diagnostics services provider in North-Eastern states


India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod
Drug Approval | December 28, 2021

India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod

It plans to deliver over 300 million doses to the Indian government